Sujane Kandasamy1,2, Ahmad Firas Khalid2,3, Umair Majid4, Meredith Vanstone2,5. 1. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON. 2. Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON. 3. Health Policy PhD Program, McMaster University, Hamilton, ON. 4. Health Research Methodology MSc Program, McMaster University, Hamilton, ON. 5. Department of Family Medicine, McMaster University, Hamilton, ON.
Abstract
BACKGROUND: Men with low- to intermediate-risk prostate cancer are typically asked to choose from a variety of treatment options, including active surveillance, radical prostatectomy, or brachytherapy. The Prolaris cell cycle progression test is intended to provide additional information on personal risk status to assist men with prostate cancer in their choice of treatment. To assist with assessing that new technology, this report synthesizes qualitative research on how men with prostate cancer use information to make decisions about treatment options. METHODS: We performed a systematic review and qualitative meta-synthesis to retrieve and synthesize findings across primary qualitative studies that report on patient perspectives during prostate cancer treatment decision-making. RESULTS: Of 8,610 titles and abstracts reviewed, 29 studies are included in this report. Most men diagnosed with prostate cancer express that their information-seeking pathway extends beyond the medical information received from their health care provider. They access other social resources to attain additional medical information, lived-experience information, and medical administrative information to help support their final treatment decision. Men value privacy, trust, honesty, control, power, organization, and open communication during interactions with their health care providers. They also emphasize the importance of gaining comfort with their treatment choice, having a chance to confirm their health care provider's recommendations (validation of treatment plan), and exercising their preferred level of independence in the treatment decision-making process. CONCLUSIONS: Although each prostate cancer patient is unique, studies suggest that most patients seek extensive information to help inform their treatment decisions. This may happen before, during, and after the treatment choice is made. Given the amount of information patients may access, it is important that they also establish the trustworthiness of the various types and sources of information. When information conflicts, patients may be unsure about how to proceed. Open collaboration between patients and their health care providers can help patients manage and navigate their concerns so that their values and perspectives are captured in their treatment choices.
BACKGROUND:Men with low- to intermediate-risk prostate cancer are typically asked to choose from a variety of treatment options, including active surveillance, radical prostatectomy, or brachytherapy. The Prolaris cell cycle progression test is intended to provide additional information on personal risk status to assist men with prostate cancer in their choice of treatment. To assist with assessing that new technology, this report synthesizes qualitative research on how men with prostate cancer use information to make decisions about treatment options. METHODS: We performed a systematic review and qualitative meta-synthesis to retrieve and synthesize findings across primary qualitative studies that report on patient perspectives during prostate cancer treatment decision-making. RESULTS: Of 8,610 titles and abstracts reviewed, 29 studies are included in this report. Most men diagnosed with prostate cancer express that their information-seeking pathway extends beyond the medical information received from their health care provider. They access other social resources to attain additional medical information, lived-experience information, and medical administrative information to help support their final treatment decision. Men value privacy, trust, honesty, control, power, organization, and open communication during interactions with their health care providers. They also emphasize the importance of gaining comfort with their treatment choice, having a chance to confirm their health care provider's recommendations (validation of treatment plan), and exercising their preferred level of independence in the treatment decision-making process. CONCLUSIONS: Although each prostate cancerpatient is unique, studies suggest that most patients seek extensive information to help inform their treatment decisions. This may happen before, during, and after the treatment choice is made. Given the amount of information patients may access, it is important that they also establish the trustworthiness of the various types and sources of information. When information conflicts, patients may be unsure about how to proceed. Open collaboration between patients and their health care providers can help patients manage and navigate their concerns so that their values and perspectives are captured in their treatment choices.
Authors: Floyd J Fowler; Michael J Barry; Beth Walker-Corkery; Jean-Francois Caubet; David W Bates; Jeong Min Lee; Alison Hauser; Mary McNaughton-Collins Journal: J Gen Intern Med Date: 2006-07 Impact factor: 5.128
Authors: Mary McNaughton-Collins; Floyd J Fowler; Jean-Francois Caubet; David W Bates; Jeong Min Lee; Alison Hauser; Michael J Barry Journal: Am J Med Date: 2004-11-15 Impact factor: 4.965
Authors: Rachel L Shaw; Andrew Booth; Alex J Sutton; Tina Miller; Jonathan A Smith; Bridget Young; David R Jones; Mary Dixon-Woods Journal: BMC Med Res Methodol Date: 2004-03-16 Impact factor: 4.615
Authors: Maja Elisabeth Juul Søndergaard; Kirsten Lode; Svein Reidar Kjosavik; Sissel Eikeland Husebø Journal: Scand J Prim Health Care Date: 2021-11-21 Impact factor: 2.581